Riamilovir
Riamilovir is an antiviral drug whose activity is primarily directed against RNA viruses. Riamilovir acts directly on the virus's RNA-dependent RNA polymerase, thereby preventing the virus from replicating. This mechanism allows Riamilovir to effectively reduce the amount of virus, accelerate the relief of symptoms, and help reduce the severity of the disease. Riamilovir can be used in the study of acute respiratory viral infections caused by new variants of SARS-CoV-2[1].
Product Specifications
CAS Number
123606-06-4
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/riamilovir.html
Smiles
O=C1N(N=C(SC)N2)C2=NN=C1[N+]([O-])=O
Molecular Formula
C5H4N6O3S
Molecular Weight
228.19
Precautions
P261-P280-P302+P352
References & Citations
[1]A. U. Sabitov, et al. Practical Experience of Using Riamilovir in Treatment of Patients with Moderate COVID-19. Vol 65, No 7-8 (2020) > Sabitov.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 4
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Adenylosuccinate Lyase (ADSL) (NM_000026) Human Over-expression Lysate
